Quest Partners LLC Oric Pharmaceuticals, Inc. Transaction History
Quest Partners LLC
- $753 Billion
- Q4 2024
A detailed history of Quest Partners LLC transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 28,435 shares of ORIC stock, worth $216,959. This represents 0.03% of its overall portfolio holdings.
Number of Shares
28,435
Previous 1,054
2597.82%
Holding current value
$216,959
Previous $10.8 Million
2023.94%
% of portfolio
0.03%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ORIC
# of Institutions
132Shares Held
67.3MCall Options Held
404KPut Options Held
6.4K-
Nextech Invest Ag5.29MShares$40.3 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$36.9 Million0.0% of portfolio
-
Viking Global Investors LP4.43MShares$33.8 Million0.12% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$33.5 Million5.85% of portfolio
-
Alkeon Capital Management LLC New York, NY3.9MShares$29.8 Million0.07% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $302M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...